Gastric cancer is the second most frequent cause of cancer-related death worldwide,1 and the number of deaths due to gastric cancer is about 15% of the total cancer deaths in Japan.2 Esophagogastroduodenoscopy (EGD) is widely used for the screening of gastric cancer in Japan;3 however, skill is required to detect small gastric cancers by this method. Such cancers are often missed by EGD; the reported miss rate for gastric cancers is approximately 20%.4 Although image-enhanced endoscopic technologies such as narrow-band imaging (NBI)5 and flexible spectral imaging color enhancement (FICE)6 have been developed, they are not sufficient to improve the detection rate of gastric cancers.
Hyperspectral imaging (HSI) represents a hybrid modality of optical diagnostics that obtains spectroscopic information and renders it in image form.7 This technology has been used in the field of remote sensing. The HSC1700 hyperspectral camera (HSC; EBA JAPAN Co., Ltd., Tokyo, Japan) is equipped with HSI technology, and the images recorded by the HSC1700 include spectral reflectance (SR) at 72 spectral bands in the wavelength range from 400 to 800 nm, at wavelength intervals of approximately 5.6 nm. Satori et al. reported that at these intervals, it was possible to distinguish slight changes of color with a high degree of accuracy.8
We recorded gastroduodenal tumors removed by endoscopic resection or surgery using HSC and found a difference of SR between tumors and normal mucosa in resected specimens ex vivo. The goal of the present study was to develop a new method for detecting gastric cancers based on differences in SR between tumors and normal mucosa.
A total of 16 lesions from 14 patients who were treated in Yamaguchi University Hospital in Japan were examined. The clinicopathological characteristics of the lesions are shown in Table 1. In the study, 10 early gastric carcinomas and 4 gastric adenomas were endoscopically resected, and 1 advanced gastric carcinoma and 1 carcinoma of the duodenum were surgically resected. These resected specimens were used for evaluation of SR by HSC.
Characteristics of the cases recorded by HSC.
|Group||Case no.||Sex||Age (y)||Treatment method||Location||Histopathologic diagnosis||Depth||Macroscopic type||Color||Tumor size (mm)|
Note: ER, endoscopic resection; U, upper third of the stomach; M, middle third of the stomach; L, lower third of the stomach; D, duodenum; Tub1, well-differentiated adenocarcinoma; Tub2, moderately differentiated adenocarcinoma; Pap, papillary adenocarcinoma; m, mucosa; sm, submucosa; ss, subserosa; Same, same color as normal mucosa.
We obtained institutional review board approval from our university. The patients received complete information on this study before providing their consent for participation, and research was carried out in accordance with the Declaration of Helsinki.
Characteristics of the HSC1700
The HSC1700 can obtain SR for 72 spectral bands in the wavelength range from 400 to 800 nm in an image with a size of pixels. A representative HSC image and SR data for each wavelength in tumorous and normal mucosae from Case 1 are shown in Fig. 1. The SR at all pixels in the image can be evaluated with HSC analysis software (HSD Analysiser; EBA JAPAN Co.). The obtained SR is normalized to one on the basis of white reference data.
Recording Procedure with the HSC
The 16 resected specimens were washed with buffered saline and as much of the mucus as possible was removed; then the specimens were pinned on blackboards and immediately recorded with the HSC. All specimens were illuminated equally using the diffused light of three 250-W halogen lamps. The distance between the HSC and the specimen was 50 cm (Fig. 2). Images of the tumors and surrounding normal mucosa could be obtained for all specimens.
Pathological Evaluation of the Resected Specimens
After being recorded by HSC, the resected specimens were fixed in 10% buffered formalin. We followed the 14th edition of the Japanese Classification of Gastric Carcinoma with regard to the handling of resected specimens.9 The fixed specimens were sectioned at 2-mm intervals and stained with hematoxylin and eosin. The border between the tumor and normal mucosa was diagnosed by histopathological examination. All lesions were curatively resected with a sufficient margin.
Analysis of the SRs of Tumors and Normal Mucosae
The method of supervised learning was used to establish a diagnostic algorithm and evaluate its diagnostic capability.10 The 16 cases were divided into eight training cases and eight test cases. The training cases were used to determine the optimal wavelength and cutoff point to discriminate between normal and tumorous mucosae. The test cases, which were independent of the training cases, were used to evaluate the diagnostic capability for tumors.
The SRs were obtained from 15 samples (pixels) of normal mucosae and 10 samples (pixels) of tumors from each case. Artifacts of electric cauterization and surgical margins were omitted from the measured samples. Because the SR varied in each case, the mean SR from five normal samples was used as a control for normalization. For each case, corrected spectral reflectance (cSR) was defined as follows:
Corrected spectral reflectance SR of 5 normal samples
Then the cSRs from 10 normal mucosa samples and 10 tumor samples of each case were obtained. A flowchart of the SR analysis is shown in Fig. 3.
Image Enhancement of Tumors by Image Processing
By using the HSD Analysiser, we processed the images of all lesions with 20 levels of color gradation on the basis of the SR of the optimal wavelength. Each pixel of the image was displayed in blue if the SR of the pixel was low and red if it was high. The enhanced images were classified by two endoscopists (J. Nishikawa and T. Okamoto) into the following three grades: A, the entire tumor was enhanced; B, the tumor was partially enhanced; and C, the tumor was not enhanced at all. The cases classified as A or B were defined as “enhanced,” and we examined the cases of enhancement.
Establishment of the Diagnostic Algorithm with Training Cases
The mean cSR of each wavelength from the 10 tumor samples and 10 normal samples of Case 1 is shown in Fig. 4. In the range of 600 to 800 nm, the mean cSR in the tumors tended to be higher than that in normal mucosae in the training cases. Consequently, the cutoff point was set at the intermediate value between the mean cSR of 80 tumor samples and the mean cSR of 80 normal mucosal samples from the eight training cases. We hypothesized that a cSR higher than the cutoff point indicated a tumor, and a cSR lower than the cutoff point indicated normal mucosa. To determine the optimal wavelength and cutoff point, we set a cutoff point for each wavelength and compared the sensitivity, specificity, and diagnostic accuracy. The accuracy rate using the cutoff point of 726 nm was the highest for the 72 wavelengths, and its cutoff point was 0.05084. The sensitivity, specificity, and accuracy rates were 76.2% (61/80 samples), 78.8% (63/80), and 77.5% (124/160), respectively (Fig. 5).
Validation of the Diagnostic Algorithm with Test Cases
To evaluate the diagnostic capability using the cutoff point of the optimal wavelength (726 nm) determined in training cases, we used 160 blind samples (80 tumor samples and 80 normal mucosa samples) from the test cases, independent of the training cases. The sensitivity, specificity, and accuracy rates were 78.8% (63/80 samples), 92.5% (74/80), and 85.6% (137/160), respectively, in the test cases (Fig. 6).
Evaluation of Images Enhanced by SR Data at 726 nm
HSC images of the 16 cases were processed on the basis of the SR of the wavelength of 726 nm. An image from Case 1 is shown in Fig. 7. Endoscopist J. Nishikawa classified them as follows: A, 8 cases; B, 6 cases; and C, 2 cases, whereas T. Okamoto considered the classifications to be as follows: A, 3 cases; B, 11 cases; and C, 2 cases. The number of cases evaluated as enhanced (A or B) by both endoscopists was 13 (81.3%).
Previous applications of optical spectroscopy to detect gastrointestinal cancer have been attempted. Sambongi et al. measured the spectral intensities of tumors and normal mucosae of the stomach and the colon using a fiber probe through an endoscope.11 They analyzed the SR in the range of 400 to 600 nm normalized to an SR of 640 nm, but the difference in SR between tumors and normal mucosae was not clearly identified. The usefulness of autofluorescence for cancer detection has been reported. Mayinger et al. measured the fluorescence spectra of gastric cancer by illumination with violet-blue light through a fiber probe, and a sensitivity of 84% and specificity of 87% were obtained for the diagnosis of gastric adenocarcinoma.12 Because both systems could obtain the spectral data of only a single spot, it was impossible to evaluate the spectrum over a large area of observation. By contrast, the advantage of HSI technology is that it can obtain spectral data for each pixel in an image with a large area of observation.7,8 This enables the comparison of spectral data between the tumor and normal mucosa and visualization of the difference by image processing.
We measured the SR of resected specimens of gastric cancers using the HSC1700; however, SR varied in each case. It is thought that SR is reflected mainly by surface color. Gastric cancers have various colors (ranging from reddish to discolored) in each patient. In addition, the color of the background mucosa also varies with gastritis and the grade of mucosal atrophy, and these changes may also provide variations in the SR. Therefore, the mean SR in normal mucosa was used as a control for normalization, making it possible to effectively reduce variation and determine the optimal wavelength and cutoff point to discriminate between normal and tumorous mucosae. The accuracy rate using the optimal wavelength of 726 nm was the highest among the 72 wavelengths examined in the training cases. The diagnostic algorithm based on the analysis of the training cases was applied to test cases and led to highly accurate diagnoses.
With regard to the clinical setting, we are considering that an endoscope and an HSC are connected to measure reflectance spectra of gastric cancer in vivo. When we develop such a prototype, SR of normal mucosa will be measured first, and images of cancerous areas with SR very different from the normal will be enhanced during endoscopic examination. We believe that application of HSI to endoscopic examination could decrease the incidence of missed gastric cancer.
We believe that higher specificity and fewer false negatives are preferable for cancer screening. In the present study, what resulted in a false negative was very low-grade malignant gastric cancer such as that in Case 13, which suggests that differences in SR in such cases may be small.
It is not known why the SR at 726 nm is generally higher in cancerous mucosae. We first speculated that this particular SR could be affected by the hemoglobin concentration because microvessel density correlated positively with the SR at the wavelength of 726 nm in the lesions (data not shown in this article). Oxyhemoglobin is normally the most abundant form of hemoglobin and has three peaks of absorption (418, 542, and 577 nm).13 Image-enhanced endoscopic techniques such as NBI and FICE have mainly utilized light wavelengths of 400 to 600 nm.5,6 These are suitable for the detection of capillary-rich tumors and observation of irregular microvessels on tumors with a magnifying endoscope.14,15 The 726-nm wavelength of light has a tendency to be absorbed more easily by deoxyhemoglobin.16,17 Therefore, the difference of SR at 726 nm might be associated with the deoxyhemoglobin content. We also considered other factors influencing the absorption and scattering of light. The 726-nm wavelength is near-infrared light, and it can penetrate the mucosal layer to the submucosal layer,18 so interstitial collagen in this layer might affect the SR at 726 nm.19
The limitations of this study include the small sample size and the fact that all the results obtained with the HSC were from ex vivo SR data. It is not known if the same results would be obtained with in vivo data. There is a high possibility that hemoglobin density and oxygen saturation having an effect on SR are considered to change with in vivo and ex vivo tissue. Therefore, in order to determine whether the ex vivo results of this study can be applied in vivo, we are planning to measure SR of gastric cancer in vivo.
In conclusion, we found a difference in the SR between tumors and normal mucosae ex vivo, indicating that it is possible to discriminate tumors from normal mucosae with this HSI system. Thus, HSI technology can be used in a computer-aided detection system that could potentially improve the detection rate of gastric cancers.
K. D. CrewA. I. Neugut, “Epidemiology of gastric cancer,” World J. Gastroenterol. 12(3), 354–362 (2006).WJGAF21007-9327Google Scholar
S. Hirobashi, Ed., Cancer Statistics in Japan, p. 12, Foundation for Promotion of Cancer Research, Tokyo (2009).Google Scholar
K. Aidaet al., “Clinicopathological features of gastric cancer detected by endoscopy as part of annual health checkup,” J. Gastroenterol. Hepatol. 23(4), 632–637 (2008).JGHEEO1440-1746http://dx.doi.org/10.1111/j.1440-1746.2008.05346.xGoogle Scholar
T. Vo-Dinhet al., “A hyperspectral imaging system for in vivo optical diagnostics. Hyperspectral imaging basic principles, instrumental systems, and applications of biomedical interest,” IEEE Eng. Med. Biol. Mag. 23(5), 40–49 (2004).IEMBDE0739-5175http://dx.doi.org/10.1109/MEMB.2004.1360407Google Scholar
Japanese Gastric Cancer Association, Ed., Japanese Classification of Gastric Carcinoma, 14th ed., pp. 21–25, Kanehara, Tokyo (2010).Google Scholar
M. Sambongiet al., “Analysis of spectral reflectance using normalization method from endoscopic spectroscopy system,” Opt. Rev. 9(6), 238–243 (2002).1340-6000http://dx.doi.org/10.1007/s10043-002-0238-2Google Scholar
B. Mayingeret al., “Evaluation of in vivo endoscopic autofluorescence spectroscopy in gastric cancer,” Gastrointest. Endosc. 59(2), 191–198 (2004).GAENBQ0016-5107http://dx.doi.org/10.1016/S0016-5107(03)02687-7Google Scholar
T. Nakayoshiet al., “Magnifying endoscopy combined with narrow band imaging system for early gastric cancer: correlation of vascular pattern with histopathology (including video),” Endoscopy 36(12), 1080–1084 (2000).ENDCAMhttp://dx.doi.org/10.1055/s-2004-825961Google Scholar
K. Sumiyamaet al., “Combined use of a magnifying endoscope with a narrow band imaging system and a multibending endoscope for en bloc EMR of early-stage gastric cancer,” Gastrointest. Endosc. 60(1), 79–84 (2004).GAENBQ0016-5107http://dx.doi.org/10.1016/S0016-5107(04)01285-4Google Scholar
P. Taroniet al., “Time-resolved optical spectroscopy and imaging of breast,” Opto-Electron Rev. 12(2), 249–253 (2004).OELREM1230-3402Google Scholar
W. G. ZijlstraA. BuursmaW. P. Meeuwsen-van der Roest, “Absorption spectra of human fetal and adult oxyhemoglobin, de-oxyhemoglobin, carboxyhemoglobin, and methemoglobin,” Clin. Chem. 37(9), 1633–1638 (1991).CLCHAU0009-9147Google Scholar
A. N. Bashkatovet al., “Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm,” J. Phys. D: Appl. Phys. 38(15), 2543–2555 (2005).JPAPBE0022-3727http://dx.doi.org/10.1088/0022-3727/38/15/004Google Scholar
I. Georgakoudiet al., “NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes,” Cancer Res. 62(3), 682–687 (2002).CNREA80008-5472Google Scholar